CTO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTO, covering 2016-02-19 to 2016-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure [Phase 1]